Repurposing treatments to treat multiple conditions is quicker, safer, and less expensive than developing new ways to manage ...

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...

Biomed Industries, Inc. Presented Breakthrough Unified Theory Linking Alzheimer’s Disease, Obesity and Cardiovascular ...

Experts answer four key questions based on the findings of a study that indicated that low-dose oral lithium could slow memory decline in older adults with mild cognitive impairment (MCI).

Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody ...

New findings suggest that targeting inflammation in Alzheimer’s may matter as much as targeting protein buildup.

Mandara Biopharma Inc. announced approval from the FDA to initiate their clinical trials for the treatment of agitation ...

A study tracking women for more than two decades adds to growing evidence that when menopause hormone therapy is started may influence dementia risk later in life.

Alzheimer's disease affects millions of people around the world. To study this condition, researchers must peer inside the distinctive environment of the human brain. but for scientists to get the ...

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.